The company has developed a unique process for the deterministic production of carbon nanotube (CNT) devices. This process allows Carbon Design Innovations to predictably produce CNTs with specified geometries and properties such as angle and length that offer many benefits for atomic force microscopes.
A a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. The company's sensors are designed and manufactured using microelectromechanical systems, or MEMS, technology, which enables the fabrication of millimeter-scale devices with internal features in the nanometer to micrometer range.
A fabless semi-conductor IP company developing embedded Non-Volatile Memory technology for standard CMOS processes. Its Nanomech™ technology is a novel embedded flash solution, residing in the metal interconnect system, yielding no impact to existing IP, scaling to 45nm and below.
Cavitation Technologies, Inc. (CTi) is an innovative leader in processing liquids, fluidic mixtures, emulsions and suspended solids. The Company has commercialized its patent-pending CTi Nano Neutralization process, offering the refiners of edible oils and fats significant yield improvements, substantial cost savings and environmental benefits. As an add-on to existing neutralization systems, the Company's patented Nano Reactor allows refiners to significantly reduce the processing costs, increase the yield and perfect the oil's quality.
CB Mills Inc. is a manufacturing leader of superior products used in inks, paints, chemicals, bio-chemicals, pharmaceuticals, electronics, mineral processing, waste treatment and even cosmetics industries. Our versatile product range covers complete essentials for select industries. For over a century CB Mills has been growing and optimizing its diverse portfolio of leading products. Each one of its winning lines of products from grinding mills, dispensing systems, solvent recovery and washing systems has been continuously enhanced to adapt to today?s standards while employing state-of-the-art technologies.
Celera has a successful molecular diagnostics business and powerful genomic and proteomic discovery platforms that have identified and validated new drug targets and biomarkers that will advance the practice of Targeted Medicine.
Celsense is a biotechnology company offering novel MRI contrast agents (fluorochemical nanoparticles) that allow scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo.